Back to Search

MICHAEL HASEMAN, MD

MD

Nuclear Medicine Physician

NPI: 1073519781Individual

Specialties, Licenses & Credentials

Nuclear Medicine PhysicianPrimary

Nuclear Medicine

Code: 207U00000X

G44379(CA)
Nuclear Cardiology Physician

Nuclear Medicine — Nuclear Cardiology

Code: 207UN0901X

G44379(CA)
Nuclear Imaging & Therapy Physician

Nuclear Medicine — Nuclear Imaging & Therapy

Code: 207UN0902X

G44379(CA)
In Vivo & In Vitro Nuclear Medicine Physician

Nuclear Medicine — In Vivo & In Vitro Nuclear Medicine

Code: 207UN0903X

G44379(CA)

Research & Publications (5)

Central abdominal uptake of indium-111 capromab pendetide (ProstaScint) predicts for poor prognosis in patients with prostate cancer.
PMID 17826494·Urology·2007
8-other
Capromab Pendetide imaging of prostate cancer.
PMID 10803318·Cancer Biother Radiopharm·2000
6-review
The role of (111)In Capromab Pendetide (Prosta-ScintR) immunoscintigraphy in the management of prostate cancer.
PMID 12114876·Q J Nucl Med·2002
6-review
Utility of capromab pendetide (ProstaScint) imaging in the management of prostate cancer.
PMID 11272670·Tech Urol·2001
6-review
Surgical confirmation of ProstaScint abnormalities in two patients with high risk prostate cancer.
PMID 11268308·Can J Urol·2001
5-case

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
2241 DOUGLAS BLVD, STE 110
ROSEVILLE, CA 95661

Location

Practice Location

2241 DOUGLAS BLVD, ROSEVILLE, CA
(916) 783-8900

Quick Facts

NPI
1073519781
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
4
Locations
1
Publications
5

Are you this provider?

Claim Your Profile